Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma

EV demonstrated comparable efficacy and tolerability in patients aged ≥80 years relative to younger counterparts. These findings support the safe and effective use of EV in elderly patients with mUC and highlight the need for further prospective studies in this population.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-09-26
DOI
https://doi.org/10.21873/anticanres.17803
Citations
1
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma

Hirofumi Morinaka, Kiyoshi Takahara, Takuya Tsujino, Hisayoshi Niigawa et al.
1 citations
Anticancer Research
Bladder and Urothelial Cancer Treatments
2.01
article

Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial Carcinoma

Hirofumi Morinaka, Kiyoshi Takahara, Takuya Tsujino, Hisayoshi Niigawa, Atsuhiko Yoshizawa, Mamoru Hashimoto, Fumihiko Urabe, Kensuke Hirosuna, Takafumi Minami, Ryoichi Maenosono, Wataru Fukuokaya, Haruhito Azuma, Keiichiro Mori, Kyosuke Nishio, KAZUKI NISHIMURA, Takafumi Yanagisawa, S Kakumae, Taeho Jo, Yutaka Yoshikawa, Masanobu Saruta, Teruo Inamoto, Kazumasa Komura, Kazutoshi Fujita, Takahiro Kimura, Shunsuke Tsuduki, Moritoshi Sakamoto, Taizo Uchimoto, Yutaka Yamamoto
article en
1 citations

Abstract

EV demonstrated comparable efficacy and tolerability in patients aged ≥80 years relative to younger counterparts. These findings support the safe and effective use of EV in elderly patients with mUC and highlight the need for further prospective studies in this population.

Anticancer ResearchVol. 45(10)
Jikei University School of Medicine (JP), Fujita Health University (JP), Kawasaki Medical School (JP), Hamamatsu University School of Medicine (JP), Osaka University of Pharmaceutical Sciences (JP), Kindai University (JP)
Openalex Percentile: Top 11%
Bladder and Urothelial Cancer Treatments
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.